Lymphoma and other malignancies in primary Sjögren's syndrome

Annals of the Rheumatic Diseases

Volumn 65, Issue 6, 2006, Pages 704-706

  Pillemer, S R ^a  

^a MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; INTERFERON; PROTEIN BCL 2; TOLL LIKE RECEPTOR 7;

APOPTOSIS; B CELL LYMPHOMA; CANCER GROWTH; CANCER INCIDENCE; CANCER REGRESSION; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL FEATURE; DNA STRAND BREAKAGE; EDITORIAL; HEMATOLOGIC MALIGNANCY; HUMAN; INFLAMMATION; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MUTAGENICITY; ONCOGENE C MYC; PRIORITY JOURNAL; PURPURA; SJOEGREN SYNDROME; SOMATIC MUTATION; VASCULITIS;

CD4 LYMPHOCYTE COUNT; COMPLEMENT C3; COMPLEMENT C4; DISEASE SUSCEPTIBILITY; HUMANS; LYMPHOMA, B-CELL; RISK FACTORS; SJOGREN'S SYNDROME; SKIN NEOPLASMS; VASCULITIS;

EID: 33744500227     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.044362     Document Type: Editorial

References (19)

1. Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LTH. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006;65:796-803.
2. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
3. Jonsson R, Moen K, Vestrheim D, Szodoray P. Current issues in Sjögren's syndrome. Oral Dis 2002;8:130-40.
4. Harris NL. Lymphoid proliferations of the salivary glands. Am J Clin Pathol 1999;711(suppl 1):S94-103.
5. Masaki Y, Sugai S. Lymphoproliferative disorders in Sjögren's syndrome. Autoimmun Rev 2004;3:175-82.
6. Mackay IR, Rose NR. Autoimmunity and lymphoma: tribulations of B cells. Nat Immunol 2001;2:793-5.
7. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-92.
8. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjögren's syndrome. Arthritis Rheum 1999;42:1765-72.
9. Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, et al. Association of BAFF/BLyS over expression and altered B cell differentiation with Sjögren's syndrome. J Clin Invest 2002;109:17-18.
10. Nishimura M, Miyajima S, Okada N. Salivary gland MALT lymphoma associated with Helicobacter pylori infection in a patient with Sjögren's syndrome. J Dermatol 2000;27:450-2.
11. Klussmann JP, Wagner M, Guntinas-Lichius O, Muller A. Detection of HHV-8 sequences and antigens in a MALT lymphoma associated with Sjögren's syndrome. J Oral Pathol Med 2003;32:243-5.
12. Savio A, Franzin G, Wotherspoon AC, Zamboni G, Negrini R, Buffoli F, et al. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood 1996;87:1255-60.
13. Theander E, Nilsson I, Manthorpe R, Jacobsson LT, Wadstrom T. Seroprevalence of Helicobacter pylori in primary Sjögren's syndrome. Clin Exp Rheumatol 2001;19:633-8.
14. Gottenberg JE, Lavie F, Abbed K, Gasnault J, Le Nevot E, Delfraissy JF, et al. CD4 CD25 high regulatory T cells are not impaired in patients with primary Sjögren's syndrome. J Autoimmun 2005;24:235-42.
15. Szodoray P, Jellestad S, Teague MO, Jonsson R. Attenuated apoptosis of B cell activating factor-expressing cells in primary Sjögren's syndrome. Lab Invest 2003;83:357-65.
16. Båve U, Nordmark G, Lovgren T, Ronnelid J, Cajander S, Eloranta ML, et al. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum 2005;52:1185-95.
17. Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. Arthritis Rheum 2005;52:1534-44.
18. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002;46:741-7.
19. Carroll MC. The complement system in B cell regulation. Mol Immunol 2004;41:141-6.